Ignite Creation Date:
2024-05-05 @ 9:39 PM
Last Modification Date:
2024-10-26 @ 10:07 AM
Study NCT ID:
NCT00932451
Status:
COMPLETED
Last Update Posted:
2017-01-13
First Post:
2009-06-30
Brief Title:
An Investigational Drug PF-02341066 Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase ALK Gene
Sponsor:
Organization:
Pfizer